Nafamostat Mesilate Improves Sepsis Outcomes by Modulating Complement and Coagulation Pathways

ABSTRACT: Supporting data for: Nafamostat Mesilate Improves Sepsis Outcomes by Modulating Complement and Coagulation Pathways

ORGANISM(S): Homo Sapiens

SUBMITTER: Ming Zhong  

PROVIDER: PXD074871 | iProX | Tue Feb 24 00:00:00 GMT 2026

REPOSITORIES: iProX